Home Dermatology PDF: Use of Nemolizumab in the Treatment of Prurigo Nodularis and Atopic Dermatitis
image of skin with medecine working through it

Article

PDF: Use of Nemolizumab in the Treatment of Prurigo Nodularis and Atopic Dermatitis

$1.99

PDF Download: Nemolizumab, an IL-31 receptor antagonist, has demonstrated high efficacy and a favourable safety profile in phase 3 trials for prurigo nodularis and atopic dermatitis. Patients showed significant reductions in itch, improved skin lesions, and better quality of life over extended treatment periods.
Read online:
Use of Nemolizumab in the Treatment of Prurigo Nodularis and Atopic Dermatitis

Category:

Related products

© SkinTherapyLetter. All rights reserved.